Inovio Trade 29/06/20
Inovio 
INO performed incredibly well last week due do a $71 grant from the DoD and pending Phase 1 results of INO-4800 which were said to be realeased late June.
Expect a dip, before rising to analysts target of $45.
Fundemental Analysis
1. Dr Fauci announced yesterday evening that positive vaccine results were to be released over the next few days.
2. China and South Korea implementation of Phase 1 which will be funded by CEPI.
3. S. Korea, BARDA and DARPA funding to come.
4. Likely approval from FDA to go onto phase 3 trials when results are confirmed to be positive.
Technical Analysis
1. Volume picking up massively this last week, as RobinHood traders continue to get on board.
2. RSI fallen towards 50 after Fridays slight fall in stock price, giving the stock a chance for another sudden rise in prices.
3. Strong support levels around 27.55 and 23.51
INO performed incredibly well last week due do a $71 grant from the DoD and pending Phase 1 results of INO-4800 which were said to be realeased late June.Expect a dip, before rising to analysts target of $45.
Fundemental Analysis
1. Dr Fauci announced yesterday evening that positive vaccine results were to be released over the next few days.
2. China and South Korea implementation of Phase 1 which will be funded by CEPI.
3. S. Korea, BARDA and DARPA funding to come.
4. Likely approval from FDA to go onto phase 3 trials when results are confirmed to be positive.
Technical Analysis
1. Volume picking up massively this last week, as RobinHood traders continue to get on board.
2. RSI fallen towards 50 after Fridays slight fall in stock price, giving the stock a chance for another sudden rise in prices.
3. Strong support levels around 27.55 and 23.51
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.